US Stock MarketDetailed Quotes

Dare Bioscience (DARE)

Watchlist
  • 2.110
  • -0.010-0.47%
Close Apr 24 16:00 ET
  • 2.111
  • +0.001+0.02%
Pre 07:41 ET
30.72MMarket Cap-1.76P/E (TTM)

Dare Bioscience (DARE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
10,429.36%1.03M
1,708.36%1.02M
-94.57%2.26K
-194.36%-21.17K
173.35%25.43K
-99.65%9.78K
-103.52%-63.65K
-95.83%41.69K
22.44K
9.3K
Operating revenue
10,429.36%1.03M
1,708.36%1.02M
-94.57%2.26K
-194.36%-21.17K
173.35%25.43K
-99.65%9.78K
-103.52%-63.65K
-95.83%41.69K
--22.44K
--9.3K
Cost of revenue
295.8K
295.8K
0
0
0
0
0
7.67K
Gross profit
734.39K
727.88K
-94.57%2.26K
-194.36%-21.17K
1,461.86%25.43K
-95.83%41.69K
22.44K
1.63K
Operating expense
-39.11%14.29M
-58.76%2.2M
-22.20%3.67M
-48.43%3.81M
-23.53%4.61M
-30.48%23.46M
-23.60%5.33M
-49.74%4.72M
-17.88%7.38M
-28.14%6.02M
Selling and administrative expenses
-4.29%8.76M
-20.99%1.58M
22.44%2.5M
-2.87%2.38M
-13.53%2.31M
-24.39%9.16M
-35.19%2M
-25.00%2.04M
-16.89%2.45M
-20.58%2.67M
-General and administrative expense
-4.29%8.76M
-20.99%1.58M
22.44%2.5M
-2.87%2.38M
-13.53%2.31M
-24.39%9.16M
-35.19%2M
-25.00%2.04M
-16.89%2.45M
-20.58%2.67M
Research and development costs
-61.39%5.52M
-81.35%622.04K
-56.18%1.18M
-71.04%1.43M
-31.49%2.3M
-33.58%14.31M
-12.20%3.34M
-59.82%2.68M
-18.36%4.93M
-33.20%3.35M
Other operating expenses
----
----
----
----
----
0.00%100K
----
----
----
----
Operating profit
42.21%-13.55M
72.69%-1.47M
21.56%-3.67M
47.99%-3.83M
23.93%-4.58M
24.20%-23.45M
-4.19%-5.39M
44.25%-4.68M
18.13%-7.36M
28.16%-6.02M
Net non-operating interest income expense
Other net income (expense)
-99.21%153.06K
125.00%29.55K
617.12%109.38K
-100.93%-188.68K
127.67%202.81K
2,391.74%19.4M
-203.78%-118.2K
-121.73%-21.15K
8,824.69%20.27M
-315.46%-732.88K
Special income (charges)
--0
--0
--0
--0
----
--20.38M
--0
--0
--20.38M
----
-Gain on sale of property,plant,equipment
--0
--0
--0
--0
----
--20.38M
--0
--0
--20.38M
----
Other non- operating income (expenses)
115.59%153.06K
125.00%29.55K
617.12%109.38K
-72.70%-188.68K
127.67%202.81K
-226.08%-981.49K
-203.78%-118.2K
-121.73%-21.15K
-148.10%-109.25K
-315.46%-732.88K
Income before tax
-230.55%-13.4M
73.82%-1.44M
24.24%-3.56M
-131.11%-4.02M
35.19%-4.38M
86.56%-4.05M
-8.87%-5.51M
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
Income tax
Net income
-230.55%-13.4M
73.82%-1.44M
24.24%-3.56M
-131.11%-4.02M
35.19%-4.38M
86.56%-4.05M
-8.87%-5.51M
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
Net income continuous Operations
-230.55%-13.4M
73.82%-1.44M
24.24%-3.56M
-131.11%-4.02M
35.19%-4.38M
86.56%-4.05M
-8.87%-5.51M
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
Minority interest income
Net income attributable to the parent company
-230.55%-13.4M
73.82%-1.44M
24.24%-3.56M
-131.11%-4.02M
35.19%-4.38M
86.56%-4.05M
-8.87%-5.51M
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-230.55%-13.4M
73.82%-1.44M
24.24%-3.56M
-131.11%-4.02M
35.19%-4.38M
86.56%-4.05M
-8.87%-5.51M
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
Basic earnings per share
-150.00%-1.2
96.92%-0.02
49.09%-0.28
-129.41%-0.45
38.27%-0.5
88.43%-0.48
7.14%-0.65
49.54%-0.55
225.46%1.53
25.00%-0.81
Diluted earnings per share
-150.00%-1.2
96.92%-0.02
49.09%-0.28
-129.61%-0.45
38.27%-0.5
88.43%-0.48
7.14%-0.65
49.54%-0.55
224.64%1.52
25.00%-0.81
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 10,429.36%1.03M1,708.36%1.02M-94.57%2.26K-194.36%-21.17K173.35%25.43K-99.65%9.78K-103.52%-63.65K-95.83%41.69K22.44K9.3K
Operating revenue 10,429.36%1.03M1,708.36%1.02M-94.57%2.26K-194.36%-21.17K173.35%25.43K-99.65%9.78K-103.52%-63.65K-95.83%41.69K--22.44K--9.3K
Cost of revenue 295.8K295.8K000007.67K
Gross profit 734.39K727.88K-94.57%2.26K-194.36%-21.17K1,461.86%25.43K-95.83%41.69K22.44K1.63K
Operating expense -39.11%14.29M-58.76%2.2M-22.20%3.67M-48.43%3.81M-23.53%4.61M-30.48%23.46M-23.60%5.33M-49.74%4.72M-17.88%7.38M-28.14%6.02M
Selling and administrative expenses -4.29%8.76M-20.99%1.58M22.44%2.5M-2.87%2.38M-13.53%2.31M-24.39%9.16M-35.19%2M-25.00%2.04M-16.89%2.45M-20.58%2.67M
-General and administrative expense -4.29%8.76M-20.99%1.58M22.44%2.5M-2.87%2.38M-13.53%2.31M-24.39%9.16M-35.19%2M-25.00%2.04M-16.89%2.45M-20.58%2.67M
Research and development costs -61.39%5.52M-81.35%622.04K-56.18%1.18M-71.04%1.43M-31.49%2.3M-33.58%14.31M-12.20%3.34M-59.82%2.68M-18.36%4.93M-33.20%3.35M
Other operating expenses --------------------0.00%100K----------------
Operating profit 42.21%-13.55M72.69%-1.47M21.56%-3.67M47.99%-3.83M23.93%-4.58M24.20%-23.45M-4.19%-5.39M44.25%-4.68M18.13%-7.36M28.16%-6.02M
Net non-operating interest income expense
Other net income (expense) -99.21%153.06K125.00%29.55K617.12%109.38K-100.93%-188.68K127.67%202.81K2,391.74%19.4M-203.78%-118.2K-121.73%-21.15K8,824.69%20.27M-315.46%-732.88K
Special income (charges) --0--0--0--0------20.38M--0--0--20.38M----
-Gain on sale of property,plant,equipment --0--0--0--0------20.38M--0--0--20.38M----
Other non- operating income (expenses) 115.59%153.06K125.00%29.55K617.12%109.38K-72.70%-188.68K127.67%202.81K-226.08%-981.49K-203.78%-118.2K-121.73%-21.15K-148.10%-109.25K-315.46%-732.88K
Income before tax -230.55%-13.4M73.82%-1.44M24.24%-3.56M-131.11%-4.02M35.19%-4.38M86.56%-4.05M-8.87%-5.51M43.34%-4.7M247.34%12.91M16.00%-6.76M
Income tax
Net income -230.55%-13.4M73.82%-1.44M24.24%-3.56M-131.11%-4.02M35.19%-4.38M86.56%-4.05M-8.87%-5.51M43.34%-4.7M247.34%12.91M16.00%-6.76M
Net income continuous Operations -230.55%-13.4M73.82%-1.44M24.24%-3.56M-131.11%-4.02M35.19%-4.38M86.56%-4.05M-8.87%-5.51M43.34%-4.7M247.34%12.91M16.00%-6.76M
Minority interest income
Net income attributable to the parent company -230.55%-13.4M73.82%-1.44M24.24%-3.56M-131.11%-4.02M35.19%-4.38M86.56%-4.05M-8.87%-5.51M43.34%-4.7M247.34%12.91M16.00%-6.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -230.55%-13.4M73.82%-1.44M24.24%-3.56M-131.11%-4.02M35.19%-4.38M86.56%-4.05M-8.87%-5.51M43.34%-4.7M247.34%12.91M16.00%-6.76M
Basic earnings per share -150.00%-1.296.92%-0.0249.09%-0.28-129.41%-0.4538.27%-0.588.43%-0.487.14%-0.6549.54%-0.55225.46%1.5325.00%-0.81
Diluted earnings per share -150.00%-1.296.92%-0.0249.09%-0.28-129.61%-0.4538.27%-0.588.43%-0.487.14%-0.6549.54%-0.55224.64%1.5225.00%-0.81
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More